18.01.2023 07:00 | SCLP | Notice of Interim Results | RNS |
06.12.2022 16:40 | SCLP | Second Price Monitoring Extn | RNS |
06.12.2022 16:35 | SCLP | Price Monitoring Extension | RNS |
21.11.2022 15:18 | SCLP | Result of Annual General Meeting | RNS |
07.11.2022 12:56 | SCLP | Scancell in-licences SNAPvax technology for its Modi-2 cancer treatment | Alliance |
07.11.2022 07:00 | SCLP | Licenses Vaccitech technology to advance Modi-2 | RNS |
31.10.2022 07:00 | SCLP | First patient dosed in expansion phase of ModiFY | RNS |
28.10.2022 15:00 | SCLP | Notice of AGM | RNS |
28.10.2022 11:57 | SCLP | IN BRIEF: Scancell narrows annual loss as vaccine candidates progress | Alliance |
28.10.2022 07:00 | SCLP | Results for the year ended 30 April 2022 | RNS |
26.10.2022 14:30 | SCLP | IN BRIEF: Scancell executive chair and co-founder both to depart | Alliance |
26.10.2022 07:00 | SCLP | Directorate Changes | RNS |
25.10.2022 16:42 | SCLP | Second Price Monitoring Extn | RNS |
25.10.2022 16:37 | SCLP | Price Monitoring Extension | RNS |
25.10.2022 14:05 | SCLP | Second Price Monitoring Extn | RNS |
25.10.2022 14:00 | SCLP | Price Monitoring Extension | RNS |
25.10.2022 11:05 | SCLP | Second Price Monitoring Extn | RNS |
25.10.2022 11:00 | SCLP | Price Monitoring Extension | RNS |
25.10.2022 10:44 | JLP, EEE, SCLP | AIM WINNERS & LOSERS: Scancell signs deal; Empire Metals seeks copper | Alliance |
25.10.2022 10:03 | SCLP | Scancell shares rocket on potentially lucrative Genmab licensing deal | Alliance |
25.10.2022 07:00 | SCLP | Signs Commercial License Agreement with Genmab | RNS |
13.10.2022 07:00 | SCLP | Change of Nominated Adviser | RNS |
28.09.2022 12:31 | SCLP | Holding(s) in Company | RNS |
23.09.2022 07:00 | SCLP | Preclinical data at the EuroMAbNet Annual Meeting | RNS |
06.09.2022 12:54 | SCLP | Change of Registered Office | RNS |
16.08.2022 17:51 | SCLP | IN BRIEF: Scancell doses first patient in Modi-1 cancer trial | Alliance |
16.08.2022 14:00 | SCLP | First patient dosed in Cohort 2 of the ModiFY | RNS |
23.06.2022 21:28 | AAU, AAZ, JSGI | TRADING UPDATES: FirstGroup extends takeover date; Tasty repays debt | Alliance |
23.06.2022 07:00 | SCLP | Scancell to produce TCB antibodies | RNS |
15.06.2022 14:06 | SCLP | Second Price Monitoring Extn | RNS |
15.06.2022 14:00 | SCLP | Price Monitoring Extension | RNS |
15.06.2022 12:19 | SCLP | Scancell shares jump as phase 2 trial of skin cancer drug expands | Alliance |
15.06.2022 07:00 | SCLP | Phase 2 SCOPE trial of SCIB1 vaccine expanded | RNS |
13.06.2022 20:42 | SCLP | IN BRIEF: Scancell says first patient dosed in Modi-1 trial for cancer | Alliance |
13.06.2022 07:00 | SCLP | First patient dosed in Modi-1 Phase 1 trial | RNS |
12.04.2022 15:47 | SCLP | Change of Registered Holder of Shares | RNS |
11.04.2022 14:06 | SCLP | Second Price Monitoring Extn | RNS |
11.04.2022 14:00 | SCLP | Price Monitoring Extension | RNS |
11.04.2022 11:17 | SCLP | Scancell shares soar as clinical trial opens for recruitment | Alliance |
11.04.2022 11:05 | SCLP | Second Price Monitoring Extn | RNS |
11.04.2022 11:00 | SCLP | Price Monitoring Extension | RNS |
11.04.2022 07:00 | SCLP | Modi-1 Phase 1/2 trial open for recruitment | RNS |
29.03.2022 20:21 | SCLP | IN BRIEF: Scancell broadens Covidity clinical trial in South Africa | Alliance |
29.03.2022 07:00 | SCLP | Update on COVIDITY clinical trial | RNS |
17.03.2022 21:02 | MOS, GIF, BKY | TRADING UPDATES: SimiGon merger to go ahead; Segro launches green bond | Alliance |
17.03.2022 07:00 | SCLP | Scancell progresses its new anti-glycan mAb | RNS |
03.03.2022 09:55 | SCLP | Director Dealing | RNS |
22.02.2022 11:50 | SCLP | Image Scan sinks as it expects to post significant loss in first half | Alliance |
31.01.2022 07:00 | SCLP | Update on COVIDITY Phase 1 clinical trial | RNS |
26.01.2022 07:00 | SCLP | Interim Results for the 6 months ended 31 Oct 2021 | RNS |
22.12.2021 09:45 | SCLP | Notice of Interim Results | RNS |
13.12.2021 16:41 | SCLP | Second Price Monitoring Extn | RNS |
13.12.2021 16:36 | SCLP | Price Monitoring Extension | RNS |
23.11.2021 15:58 | SCLP | Result of AGM | RNS |
19.11.2021 07:00 | SCLP | First patient dosed in SCIB1 Phase 2 trial | RNS |
03.11.2021 10:28 | SCLP | Director Dealing | RNS |
02.11.2021 10:07 | SCLP | Director Dealing | RNS |
01.11.2021 09:50 | SCLP | Notice of Annual General Meeting | RNS |
29.10.2021 07:00 | SCLP | Results for the year ended 30 April 2021 | RNS |
28.10.2021 11:23 | SCLP | Extension of CLN Redemption Dates | RNS |
19.10.2021 07:00 | SCLP | New facilities at The Oxford Science Park | Reach |
15.10.2021 07:00 | SCLP | Notice of Final Results | RNS |
05.10.2021 16:22 | SCLP | First subject dosed in COVIDITY clinical trial | RNS |
09.09.2021 16:31 | SCLP | PDMR dealing | RNS |
26.08.2021 07:00 | SCLP | Modi-1 Phase I/II CTA approved by MHRA | RNS |
17.08.2021 07:00 | SCLP | Scancell selects PharmaJet’s Needle-free Systems | RNS |
30.07.2021 09:52 | SCLP | Director Dealing | RNS |
29.07.2021 07:00 | SCLP | COVIDITY Phase 1 trial application in SA approved | RNS |
28.07.2021 17:00 | SCLP | Lindy Durrant appointed CEO of Scancell | RNS |
22.06.2021 07:00 | SCLP | COVIDITY trial planned in South Africa and UK | RNS |
15.06.2021 07:00 | SCLP | Appointment of Joint Broker | RNS |
08.06.2021 16:41 | SCLP | Second Price Monitoring Extn | RNS |
08.06.2021 16:35 | SCLP | Price Monitoring Extension | RNS |
07.06.2021 08:49 | SCLP | Director Dealing | RNS |
30.04.2021 10:48 | SCLP | Director Dealing | RNS |